This inventor holds 2 USPTO granted patents. Top assignees: Adimab, LLC, Kite Pharma, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Jed Wiltzius
Introduction
Jed Wiltzius is an accomplished inventor known for his contributions to the field of biotechnology. He currently works at Kite Pharma, Inc., where he focuses on developing innovative therapies. His work has significant implications for cancer treatment and immunotherapy.
Latest Patents
Jed Wiltzius holds a patent for a "Chimeric Antigen and T Cell Receptors and Methods of Use." This patent represents a crucial advancement in the development of targeted therapies that harness the body's immune system to fight cancer. His innovative approach has the potential to improve patient outcomes significantly.
Career Highlights
Throughout his career, Jed has made notable contributions to the field of immunotherapy. His work at Kite Pharma, Inc. has positioned him as a key player in the development of cutting-edge cancer treatments. With a total of 1 patent, he continues to push the boundaries of what is possible in medical science.
Collaborations
Jed collaborates with talented professionals in his field, including Arianne Perez and Stuart A. Sievers. These partnerships enhance the research and development efforts at Kite Pharma, Inc., fostering an environment of innovation and creativity.
Conclusion
Jed Wiltzius exemplifies the spirit of innovation in biotechnology. His work and patents contribute significantly to the advancement of cancer therapies, showcasing the impact of dedicated inventors in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile